JP2808231B2 - Soft coated capsule - Google Patents

Soft coated capsule

Info

Publication number
JP2808231B2
JP2808231B2 JP6042122A JP4212294A JP2808231B2 JP 2808231 B2 JP2808231 B2 JP 2808231B2 JP 6042122 A JP6042122 A JP 6042122A JP 4212294 A JP4212294 A JP 4212294A JP 2808231 B2 JP2808231 B2 JP 2808231B2
Authority
JP
Japan
Prior art keywords
soft capsule
film
weight
soft
capsule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP6042122A
Other languages
Japanese (ja)
Other versions
JPH07252139A (en
Inventor
政己 諸井
智子 高橋
洋一 中嶋
敏明 倉住
勝美 今森
曜 岩佐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ESU ESU SEIYAKU KK
Original Assignee
ESU ESU SEIYAKU KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ESU ESU SEIYAKU KK filed Critical ESU ESU SEIYAKU KK
Priority to JP6042122A priority Critical patent/JP2808231B2/en
Publication of JPH07252139A publication Critical patent/JPH07252139A/en
Application granted granted Critical
Publication of JP2808231B2 publication Critical patent/JP2808231B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、軟カプセル剤同士の付
着及び軟カプセルの容器等への付着が防止され、皮膜の
透明性が維持される軟カプセル剤に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a soft capsule which prevents the soft capsules from adhering to each other and the soft capsules from adhering to a container or the like, and maintains the transparency of the film.

【0002】[0002]

【従来の技術】軟カプセル剤にはゼラチンにグリセリン
又はソルビトール等の可塑剤が配合され、これら可塑剤
により、軟カプセルの強度が向上させられている。
2. Description of the Related Art In a soft capsule, gelatin is mixed with a plasticizer such as glycerin or sorbitol, and the strength of the soft capsule is improved by these plasticizers.

【0003】しかしながら、可塑剤を添加した軟カプセ
ル剤は、吸湿しやすく、軟カプセル剤同士の付着及び容
器等への付着が起こり易いという欠点を有している。こ
のため、高温多湿の条件で保管された軟カプセル剤は、
製造時では作業効率の低下を招き、服用時では容器等か
ら取り出すことが困難であるという問題点を有してい
た。従来、このような欠点を解決するための手段として
は、軟カプセルの皮膜中に付着防止剤を添加する方法
(特開平2−180815号、特開平3−98638
号、特開平5−4914号公報)、更に軟カプセル剤の
皮膜表面に油脂類を付着させる方法(特開昭56−15
6212号、特開平1−42419号、特開平1−79
110号、特開平4−288011号、特開平6−40
891号公報)が知られている。
[0003] However, soft capsules to which a plasticizer is added have the disadvantage that they tend to absorb moisture and tend to adhere to each other and to containers and the like. For this reason, soft capsules stored under hot and humid conditions are
There has been a problem that the work efficiency is lowered during manufacturing and it is difficult to take it out of a container or the like during taking. Conventionally, as a means for solving such a drawback, a method of adding an anti-adhesion agent to the film of a soft capsule (JP-A-2-180815, JP-A-3-988638).
JP-A-5-4914) and a method of adhering fats and oils to the surface of a soft capsule film (JP-A-56-15).
No. 6212, JP-A-1-42419, JP-A-1-79
No. 110, JP-A-4-288011, JP-A-6-40
No. 891).

【0004】しかしながら、付着防止剤を添加する方法
では、得られたカプセル剤の皮膜の透明性が悪かった
り、表面に凹凸ができ服用感が低下したりする他、添加
量が多量であるため医薬品に用いる場合、薬効成分の溶
出性が低下したり、医薬品添加物の承認最大使用前例を
超えてしまうといった問題が起こり易い等の欠点があっ
た。
However, in the method of adding an anti-adhesion agent, the resulting capsule preparation film has poor transparency, the surface becomes uneven, and the feeling of taking is reduced. However, there are drawbacks such as a problem that the dissolution of a medicinal component is lowered and a problem that the excipient exceeds the maximum precedent of approved use of a pharmaceutical additive.

【0005】一方、油脂類を付着させる方法では、カプ
セル剤の付着防止効果が不十分であったり、高温多湿で
は付着防止効果が失なわれたり、更に皮膜の透明性が悪
くなり、商品価値が下がる等の課題を有していた。
On the other hand, in the method of adhering fats and oils, the effect of preventing adhesion of capsules is insufficient, the effect of preventing adhesion is lost at high temperature and high humidity, and the transparency of the film is further impaired, resulting in poor commercial value. There was a problem such as falling.

【0006】[0006]

【発明が解決しようとする課題】従って、本発明の目的
は、高温多湿の条件下でも軟カプセル剤が他のカプセル
剤又は容器等に付着せず、皮膜の透明性を維持し、室温
でも安定に長期保存できる軟カプセル剤を提供すること
にある。
Accordingly, an object of the present invention is to provide a soft capsule which does not adhere to other capsules or containers even under conditions of high temperature and high humidity, maintains the transparency of the film, and is stable even at room temperature. To provide a soft capsule which can be stored for a long period of time.

【0007】[0007]

【課題を解決するための手段】斯かる実状において本発
明者は鋭意研究を行った結果、ヒドロキシアルキル置換
セルロース又は/及びポリビニルアセタール系ポリマー
を軟カプセル剤の皮膜に透明に被覆すれば、上記付着性
が改善され、透明性が維持され、商品価値が下がらない
軟カプセル剤が得られることを見出し、本発明を完成し
た。
In this situation, the present inventors have conducted intensive studies. As a result, if the hydroxyalkyl-substituted cellulose or / and polyvinyl acetal-based polymer is transparently coated on the film of the soft capsule, the above-mentioned adhesion is obtained. The present inventors have found that a soft capsule which has improved properties, maintains transparency, and does not decrease in commercial value can be obtained, and has completed the present invention.

【0008】すなわち本発明は、ヒドロキシアルキル置
換セルロース又は/及びポリビニルアセタール系ポリマ
ーにより皮膜表面が透明に被覆された軟カプセル剤を提
供するものである。
That is, the present invention provides a soft capsule whose coating surface is transparently coated with a hydroxyalkyl-substituted cellulose and / or a polyvinyl acetal polymer.

【0009】本発明において、軟カプセル剤とは、ゼラ
チンを主体にし、可塑剤としてグリセリン、D−ソルビ
トール等を加えて皮膜を製し、皮膜中に医薬品が配合さ
れた油性液、懸濁液、粉末、顆粒、錠剤などを充填した
ソフトゼラチンカプセルをいう。
In the present invention, the soft capsule means a film mainly made of gelatin, and glycerin, D-sorbitol, etc. added as a plasticizer to form a film, and an oily liquid, suspension, A soft gelatin capsule filled with powder, granules, tablets and the like.

【0010】本発明に用いるヒドロキシアルキル置換セ
ルロースとしては、ヒドロキシプロピルメチルセルロー
ス、ヒドロキシメチルセルロース、ヒドロキシエチルセ
ルロース、ヒドロキシプロピルセルロース等が挙げられ
る。
The hydroxyalkyl-substituted cellulose used in the present invention includes hydroxypropylmethylcellulose, hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose and the like.

【0011】また、ポリビニルアセタール系ポリマーと
してはポリビニルアセタールジエチルアミノアセテート
等が挙げられる。
[0011] Examples of the polyvinyl acetal polymer include polyvinyl acetal diethylaminoacetate.

【0012】ヒドロキシアルキル置換セルロース及びポ
リビニルアセタール系ポリマーは、それぞれ単独で用い
ても混合して用いてもよく、被覆量は軟カプセル剤の皮
膜100重量部に対して0.01〜10重量部、特に
0.05〜1重量部とすることが好ましい。また、本発
明軟カプセル剤は、上記必須成分に加え、必要により、
マクロゴール、グリセリン脂肪酸エステル等を可塑剤と
して、ジメチルポリシロキサン、セラック、硬化油、カ
ルナウバロウ、ミツロウ等を滑沢剤として、又は/及び
結晶セルロース、カルメロース、カルメロースカルシウ
ム等の水に不溶性のセルロース及びその誘導体を流動化
剤として添加して被覆したものでもよいし、更に必須成
分含有層の上にこれらを被覆したものでもよい。
The hydroxyalkyl-substituted cellulose and the polyvinyl acetal-based polymer may be used alone or as a mixture. The coating amount is 0.01 to 10 parts by weight per 100 parts by weight of the soft capsule film. In particular, it is preferably 0.05 to 1 part by weight. Further, the soft capsule of the present invention, in addition to the above essential components, if necessary,
Macrogol, glycerin fatty acid ester and the like as a plasticizer, dimethylpolysiloxane, shellac, hydrogenated oil, carnauba wax, beeswax and the like as a lubricant, and / or crystalline cellulose, carmellose, water-insoluble cellulose such as carmellose calcium and The derivative may be added as a fluidizing agent and coated, or may be further coated on an essential component-containing layer.

【0013】本発明の軟カプセル剤を製造するために、
軟カプセル剤に錠剤や顆粒剤等に適用されるような通常
のコーティング方法を用いると、転動による摩擦で表面
は白色不透明となり、軟カプセル剤の透明性及び滑らか
さが失なわれ、商品価値が下ってしまう。
In order to produce the soft capsule of the present invention,
If a normal coating method such as that applied to tablets and granules is used for soft capsules, the surface becomes white and opaque due to friction due to rolling, and the transparency and smoothness of the soft capsules are lost, and commercial value Goes down.

【0014】従って、本発明の軟カプセル剤を製造する
方法としては、例えば、パン型や遠心流動型等のコーテ
ィング機で軟カプセル剤を転動させ、これに上記のコー
ティング剤の溶液を掛けるか噴霧した後、間欠転動を行
ないながら乾燥するという操作を繰り返す方法が好まし
い。
Therefore, as a method for producing the soft capsule of the present invention, for example, the soft capsule is tumbled by a pan-type or centrifugal-flow type coating machine, and the solution of the above-mentioned coating agent is applied to this. After spraying, it is preferable to repeat the operation of drying while performing intermittent rolling.

【0015】なお、この方法に限定されず、軟カプセル
剤に上記コーティング剤が透明に被覆される方法であれ
ばいかなる方法でもよい。
The method is not limited to this method, and any method may be used as long as the soft capsule is coated with the coating agent transparently.

【0016】[0016]

【発明の効果】このようにして得られた本発明の軟カプ
セル剤は、高温多湿の条件でも良好な透明性を維持し、
カプセル剤同士又はカプセル剤と容器等と付着しないの
で、室温にて極めて安定に保存することができる。更に
本発明の軟カプセル剤は、崩壊性も良好である。
The soft capsule of the present invention thus obtained maintains good transparency even under high temperature and high humidity conditions,
Since the capsules do not adhere to each other or the capsule and the container, they can be stored very stably at room temperature. Further, the soft capsule of the present invention has good disintegration properties.

【0017】[0017]

【実施例】次に実施例を挙げて本発明を更に詳細に説明
するが、本発明はこれらに限定されるものではない。
Next, the present invention will be described in more detail with reference to examples, but the present invention is not limited to these examples.

【0018】実施例1 1カプセル当りd−α−トコフェロール100mgを含有
するオウバル4号軟カプセル剤10000個(カプセル
皮膜の総重量1500g)をコーティング機(ハイコー
ターHT−48型:フロイント産業(株)製)に投入
し、毎分10回転でパンを回転させ軟カプセルを転動さ
せた。ヒドロキシプロピルメチルセルロース6gに90
重量%エタノール液114gを加えて溶解したコーティ
ング液の約20gを転動している軟カプセル剤に加えて
被覆した。被覆後、ただちに送風し、パンの回転を休止
30秒と回転5秒とを繰り返す間欠転動で、被覆軟カプ
セルを乾燥した。乾燥後、再びコーティング液の約20
gを加えて、以下同様の操作を繰り返し、所定量のコー
ティングを終了させた。得られた軟カプセル剤のヒドロ
キシプロピルメチルセルロース被覆量は皮膜重量に対し
て0.4重量%であった。
Example 1 10000 Oval No. 4 soft capsules (total weight of capsule film: 1500 g) containing 100 mg of d-α-tocopherol per capsule were coated with a coating machine (Hicoater HT-48 type: Freund Sangyo Co., Ltd.). The soft capsule was rolled by rotating the pan at 10 revolutions per minute. 90 to 6 g of hydroxypropyl methylcellulose
About 20 g of the coating solution dissolved by adding 114 g of a weight% ethanol solution was added to the rolling soft capsule and coated. Immediately after coating, air was blown, and the coated soft capsule was dried by intermittent rolling in which the rotation of the pan was stopped for 30 seconds and the rotation was repeated for 5 seconds. After drying, reapply about 20
g, and the same operation was repeated to complete the coating of a predetermined amount. The coated amount of hydroxypropylmethylcellulose in the obtained soft capsule was 0.4% by weight based on the weight of the film.

【0019】実施例2 ポリビニルアセタールジエチルアミノアセテート3gに
イソプロパノール・エタノール混液(8:2)150g
を加えて溶解したコーティング液を用いた以外は実施例
1と同様に操作した。得られた軟カプセル剤のポリビニ
ルアセタールジエチルアミノアセテート被覆量は皮膜重
量に対して0.2重量%であった。
Example 2 Isopropanol / ethanol mixed solution (8: 2) 150 g in 3 g of polyvinyl acetal diethylaminoacetate
The operation was performed in the same manner as in Example 1 except that a coating solution dissolved by adding was used. The coating amount of polyvinyl acetal diethylaminoacetate in the obtained soft capsule was 0.2% by weight based on the weight of the film.

【0020】実施例3 ヒドロキシプロピルメチルセルロース6gに90重量%
エタノール溶液114gを加えて溶解し、更にジメチル
ポリシロキサン0.3gを加えて充分に分散させたコー
ティング液を用いた以外は実施例1と同様に操作した。
得られた軟カプセル剤の被覆量は皮膜重量に対して0.
42重量%であった。
Example 3 90% by weight in 6 g of hydroxypropyl methylcellulose
The same operation as in Example 1 was carried out except that 114 g of an ethanol solution was added and dissolved, and further, 0.3 g of dimethylpolysiloxane was added and a coating solution sufficiently dispersed was used.
The coating amount of the obtained soft capsule was 0.1% based on the film weight.
It was 42% by weight.

【0021】実施例4 ヒドロキシプロピルメチルセルロース6gに90重量%
エタノール溶液114gを加えて溶解し、更に結晶セル
ロース0.3gを加えて充分に分散させたコーティング
液を用いた以外は実施例1と同様に操作した。得られた
軟カプセル剤の被覆量は皮膜重量に対して0.42重量
%であった。
Example 4 90% by weight in 6 g of hydroxypropylmethylcellulose
The same operation as in Example 1 was performed, except that 114 g of an ethanol solution was added and dissolved, and 0.3 g of crystalline cellulose was further added, and a coating solution sufficiently dispersed was used. The coating amount of the obtained soft capsule was 0.42% by weight based on the weight of the film.

【0022】実施例5 実施例2で得られた被覆された軟カプセル剤5000カ
プセル(カプセル皮膜の総重量751.5g)に、セラ
ック0.075gをエタノール30gに溶解させた液を
用いて実施例1と同様に操作し、被覆された軟カプセル
剤の表面にセラックを被覆した。得られた軟カプセル剤
のセラックの被覆量は皮膜重量に対して0.01重量%
であった。
Example 5 Example 2 was carried out using a solution prepared by dissolving 0.075 g of shellac in 30 g of ethanol in 5000 capsules (total weight of capsule film: 751.5 g) of the coated soft capsule obtained in Example 2. In the same manner as in Example 1, shellac was coated on the surface of the coated soft capsule. The shellac coating amount of the obtained soft capsule was 0.01% by weight based on the film weight.
Met.

【0023】比較例1 1カプセル当りd−α−トコフェロール100mgを含有
するフィルムコーティングを施さないオウバル4号軟カ
プセル剤を製造した。
Comparative Example 1 An Oval No. 4 soft capsule without film coating containing 100 mg of d-α-tocopherol per capsule was prepared.

【0024】比較例2 1カプセル当りd−α−トコフェロール100mgを含有
するオウバル4号軟カプセル剤3000個(カプセル皮
膜の総重量450g)を内径30cmの布引パンを取り付
けたコーティング機(2−P−S型:フロイント産業
(株)製)に投入し、パンを回転させ軟カプセルを転動
させた。これに80メッシュの篩を通過させたカルナウ
バロウ45mgを少しずつ散布して被覆した。得られた軟
カプセル剤の被覆量は皮膜重量に対して0.01重量%
であった。
Comparative Example 2 A coating machine (2-P-) equipped with 3000 Oval No. 4 soft capsules (total weight of capsule coating: 450 g) containing 100 mg of d-α-tocopherol per capsule and a cloth pan having an inner diameter of 30 cm was attached. (S type: manufactured by Freund Corporation), and the bread was rotated to roll the soft capsule. 45 mg of Carnauba wax passed through an 80-mesh sieve was sprayed little by little on this and covered. The coating amount of the obtained soft capsule was 0.01% by weight based on the weight of the film.
Met.

【0025】比較例3 アミノアルキルメタアクリレートコポリマーE6gにエ
タノール114gを加えて溶解したコーティング液を用
いた以外は実施例1と同様に操作した。得られた軟カプ
セル剤のアミノアルキルメタアクリレートコポリマーE
被覆量は皮膜重量に対して0.4重量%であった。
Comparative Example 3 The same operation as in Example 1 was carried out except that a coating solution prepared by dissolving 114 g of ethanol in 6 g of the aminoalkyl methacrylate copolymer E was used. Aminoalkyl methacrylate copolymer E of the obtained soft capsule
The coating amount was 0.4% by weight based on the film weight.

【0026】比較例4 エチルセルロース6gにエタノール114gを加えて溶
解したコーティング液を用いた以外は実施例1と同様に
操作した。得られた軟カプセル剤のエチルセルロース被
覆量は皮膜重量に対して0.4重量%であった。
Comparative Example 4 The procedure of Example 1 was repeated except that a coating solution prepared by dissolving 114 g of ethanol in 6 g of ethyl cellulose was used. The amount of ethyl cellulose coated on the obtained soft capsule was 0.4% by weight based on the weight of the film.

【0027】試験例1 実施例1〜5及び比較例1〜4で得た軟カプセル剤を2
0カプセルずつを4号規格瓶に入れ、ビン口を開口した
状態で、40℃、75%RHの恒温恒湿槽内に24時間
保存し、軟カプセル剤を室温にもどした後、直径5cm、
高さ7cmの透明の筒を用いて、倒立させた検体を机上に
垂直に落下させた。落下高さは1cm、3cm及び5cmと
し、軟カプセル剤同士の付着なしに落下した軟カプセル
数の累積数で付着防止効果を評価した。この結果を表1
に示す。
Test Example 1 The soft capsules obtained in Examples 1 to 5 and Comparative Examples 1 to 4
0 capsules each were put in a No. 4 standard bottle, and kept in a thermo-hygrostat at 40 ° C. and 75% RH for 24 hours with the bottle opening, and after returning the soft capsule to room temperature, the diameter was 5 cm.
The inverted sample was vertically dropped on a desk using a transparent tube having a height of 7 cm. The falling height was 1 cm, 3 cm and 5 cm, and the adhesion preventing effect was evaluated by the cumulative number of soft capsules that fell without sticking between the soft capsules. Table 1 shows the results.
Shown in

【0028】[0028]

【表1】 [Table 1]

【0029】試験例2 実施例1〜5及び比較例1〜4について試験液に水を用
いて、日本薬局方の崩壊試験を実施した。また、被膜の
透明度を次の3段階で評価した。 A:透明、B:わずかに曇りがある、C:曇りがある これらの結果を表2に示す。
Test Example 2 Disintegration tests according to the Japanese Pharmacopoeia were carried out for Examples 1 to 5 and Comparative Examples 1 to 4 using water as a test solution. In addition, the transparency of the coating was evaluated on the following three levels. A: transparent, B: slightly cloudy, C: cloudy These results are shown in Table 2.

【0030】[0030]

【表2】 [Table 2]

【0031】以上の結果より本発明品は、高温多湿の条
件の中でも付着防止効果及び透明性に優れ、崩壊性にも
問題は見られず、良好な軟カプセル剤であるのが分か
る。
From the above results, it can be seen that the product of the present invention is excellent in anti-adhesion effect and transparency even under high temperature and high humidity conditions, has no problem in disintegration, and is a good soft capsule.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 岩佐 曜 千葉県四街道市鹿渡886−16 (58)調査した分野(Int.Cl.6,DB名) A61K 9/48,47/32,47/38 A61J 3/07──────────────────────────────────────────────────続 き Continuation of the front page (72) Inventor You Iwasa 886-16 Shiwatari, Yotsukaido-shi, Chiba (58) Field surveyed (Int.Cl. 6 , DB name) A61K 9 / 48,47 / 32,47 / 38 A61J 3/07

Claims (2)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 ヒドロキシアルキル置換セルロース又は
/及びポリビニルアセタール系ポリマーにより皮膜表面
が透明に被覆された軟カプセル剤。
1. A soft capsule whose coating surface is transparently coated with a hydroxyalkyl-substituted cellulose and / or a polyvinyl acetal polymer.
【請求項2】 ヒドロキシアルキル置換セルロース又は
/及びポリビニルアセタール系ポリマーの被覆量が軟カ
プセル剤の皮膜100重量部に対して0.01〜10重
量部である請求項1記載の軟カプセル剤。
2. The soft capsule according to claim 1, wherein the coating amount of the hydroxyalkyl-substituted cellulose and / or polyvinyl acetal polymer is 0.01 to 10 parts by weight based on 100 parts by weight of the film of the soft capsule.
JP6042122A 1994-03-14 1994-03-14 Soft coated capsule Expired - Fee Related JP2808231B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6042122A JP2808231B2 (en) 1994-03-14 1994-03-14 Soft coated capsule

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6042122A JP2808231B2 (en) 1994-03-14 1994-03-14 Soft coated capsule

Publications (2)

Publication Number Publication Date
JPH07252139A JPH07252139A (en) 1995-10-03
JP2808231B2 true JP2808231B2 (en) 1998-10-08

Family

ID=12627152

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6042122A Expired - Fee Related JP2808231B2 (en) 1994-03-14 1994-03-14 Soft coated capsule

Country Status (1)

Country Link
JP (1) JP2808231B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111874589A (en) * 2020-08-04 2020-11-03 范林玲 Integral type glass bottle automated production equipment

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013031949A1 (en) * 2011-09-02 2013-03-07 富士フイルム株式会社 Soft capsule pharmaceutical preparation, composition for soft capsule pharmaceutical preparation, and method for producing soft capsule pharmaceutical preparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111874589A (en) * 2020-08-04 2020-11-03 范林玲 Integral type glass bottle automated production equipment

Also Published As

Publication number Publication date
JPH07252139A (en) 1995-10-03

Similar Documents

Publication Publication Date Title
US6537573B2 (en) Combination dosage form comprising cetirizine and pseudoephedrine
JP3220373B2 (en) Long-acting nifedipine preparation
JP4963767B2 (en) Controlled release formulation
CA2795324C (en) Pharmaceutical compositions comprising hydromorphone and naloxone
HU197839B (en) Process for producing metoprolol containing pharmaceutical compositions
JP2002097132A (en) Dry coated tablet of cilostazol
JP2005516020A (en) Zero-order sustained release dosage form and process for its production
KR20090065524A (en) Programmable buoyant delivery technology
IE58401B1 (en) Controlled absorption pharmaceutical composition
JPH04217918A (en) Naproxen combination drug having its absorption controlled to permit administration once a day
JPH08501081A (en) Controlled release morphine formulation
WO2014154029A1 (en) Composite structural material and pharmaceutical composition thereof
JP2010519200A (en) Controlled release formulation containing cilostazol and method for producing the same
BG65914B1 (en) Sustained-release preparations of quinolone antibiotics and method for preparation thereof
JPH02288821A (en) Particle and medicine preparation coated with film containing agonist
AU769160B2 (en) Morphine sulphate microgranules, method for preparing same and compositions containing same
JP2005533774A (en) Divalproexodium release retardant
JP2665858B2 (en) Long-acting oxybutynin hydrochloride preparation
JP2808231B2 (en) Soft coated capsule
RU2275191C2 (en) Pharmaceutical compositions consisting of multiple particles with sustained-release of serotonin reuptake selective inhibitor
US20220249385A1 (en) Extended release composition of tofacitinib
JP5105684B2 (en) Sustained pharmaceutical formulation
SE462779B (en) PHARMACEUTICAL COMPOSITION CONTAINING N-ACETYL CYSTEIN IN A CERNA COATED WITH HYDROXIPROPYLMETHYL CELLULOS AGREEMENT
WO2007015270A2 (en) Novel controlled release compositions of selective serotonin reuptake inhibitors
JP5822758B2 (en) Fast-dissolving moisture-proof film coating preparation and method for producing the same

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 19980630

LAPS Cancellation because of no payment of annual fees